Multisystem Inflammatory Syndrome in Children
📧 Sign up to get email alerts when something new happens for Multisystem Inflammatory Syndrome in Children.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University-sponsored trial evaluating pharmacokinetics, pharmacodynamics, and safety of understudied drugs given to children as part of…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children
Clinical trial update reporting long-term outcomes in children who experienced Multisystem Inflammatory Syndrome in Children (MIS-C); the st…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: MIS-C Comparative Effectiveness Study [Phase 2, Phase 3]
A comparative effectiveness study evaluating Multisystem Inflammatory Syndrome in Children (MIS-C) completed Phase 2 and Phase 3, with resul…
-
CLINICAL_TRIALS withdrawal · 2025-10-31Clinical Trial Update: Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
Expanded access program using mesenchymal stromal cells to treat MIS-C associated with COVID-19 is no longer available.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Quality of Life in Children After Multisystem Inflammatory Syndrome in Children
This document provides an update on a clinical trial evaluating quality of life in children after Multisystem Inflammatory Syndrome in Child…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease
This completed clinical trial reports on the characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and explores its rela…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Pediatric COVID Outcomes Study (PECOS)
Pediatric COVID Outcomes Study (PECOS) is an active-not-recruiting trial assessing COVID-19 and MIS-C outcomes in children.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)
A completed clinical trial evaluated the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection. The u…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: AT1001 for the Treatment of COVID-19 Related MIS-C [Phase 2]
A Phase 2 trial of AT1001 for COVID-19-related Multisystem Inflammatory Syndrome in Children has been terminated.
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: MISC COVID-19 Study in Pediatric Population
A pediatric clinical trial update indicates a MIS-C and SARS-CoV-2 infection study is currently recruiting in India.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Contrast Enhanced Ultrasound in COVID-19 [Phase 3]
Phase 3 clinical trial evaluating contrast-enhanced ultrasound in pediatric COVID-19 with results posted in March 2024.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Seroprevalence of SARS-Cov-2 Antibodies in Children
Study completed; seroprevalence of SARS-CoV-2 antibodies in children with conditions including COVID and multisystem inflammatory syndrome i…